Indefinite Delivery Contract W81K0220D0004

Award Date 4/10/20
Last Date to Order 12/31/20
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of the Navy Bureau of Medicine and Surgery awarded a blanket purchase agreement to Advanced Accelerator Applications USA Inc. to procure NETSPOT (Gallium-68 dotatate) doses. Under this IDV, the Defense Health Agency issued multiple firm fixed price calls between $11.2K-$14K to the awardee for delivery of the specified radiopharmaceutical product. Places of performance included New Jersey and New York. The radiopharmaceutical, used in positron emission tomography scans to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a single award indefinite delivery contract to Advanced Accelerator Applications USA Inc. to provide radiopharmaceutical services and support. The contract has a potential value of $483,000 and period of performance through September 30, 2022. No set-aside was used for this award. Under the contract, the prime contractor has been issued two delivery orders. The first was for an...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded an indefinite delivery contract to RLS USA Inc. for GA68 DOTATE (NETSPOT) services. The single award IDV has a total potential value of $510,000 and period of performance from March 2022 through March 2023. Under the IDV, the agency issued a firm fixed price delivery order to RLS USA Inc. for $460,395 to be performed in Dallas, Texas by March 2023. The original solicitation sought...
This federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense, to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The BPA has a ceiling value of $350,000.00 and a performance period from February 17, 2022 to February 16, 2027. The primary contracted products are Gallium-68 Dotatate (NETSPOT), a radiopharmaceutical used in nuclear medicine imaging procedures. The BPA...
The Defense Health Agency (DHA) awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $26,050,385.01 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract is for the procurement of the cancer therapy drugs LUTATHERA (lutetium Lu 177 dotatate) and PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) over a period of 5 years from October 1, 2024 to September 30, 2029. The original solicitation was a Sources...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded an indefinite delivery contract to Advanced Accelerator Applications USA Inc. to provide radiopharmaceutical gallium Ga 68 dotatate. The single award IDV has a potential value of $1,015,000 and a period of performance through January 2026. Under the IDV, the awardee has received a $126,000 firm fixed price delivery order to supply gallium Ga 68 dotatate for nuclear medicine...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a blanket purchase agreement to Advanced Accelerator Applications USA Inc. to provide Ga-68 Netspot radiopharmaceuticals and related nuclear medicine services. The BPA has a potential value of $244,000 and period of performance through December 2023. Two calls were placed against the BPA for services in Pittsburgh and Philadelphia, with values of $5,600 and $0 respectively and...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, to supply radiopharmaceutical products such as gallium-68 dotatate. Valued at a ceiling of $1.5 million, this IDC has a period of performance through March 2026 and was awarded to Jubilant Radiopharma under unrestricted competition, with no set-aside designation....
The Department of Veterans Affairs (VA), Network Contracting Office 6, awarded a single-award Indefinite Delivery Contract (IDC) to Petnet Solutions, Inc., a subsidiary of Siemens AG, to provide specialized radiopharmaceutical supplies. The $2.9 million IDC, awarded on March 1, 2024, has a period of performance through February 28, 2026. Under this IDC, the VA issued a $630,728 firm fixed-price delivery order for the supply of FDG, Axumin, Amyvid, and Tauvid radioactive tracers and calibration...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The $7.5 million single-award BPA, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), covers the delivery of PLUVICTO and LUTATHERA, which are radiopharmaceutical products used for cancer treatment and diagnostic imaging. The VA has awarded Advanced Accelerator...
  • W81K0220D0004
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The U.S. Army Medical Command (MEDCOM) awarded an Indefinite Delivery Contract (IDC) to Advanced Accelerator Applications USA Inc., a radiopharmaceutical company, to provide Gallium Ga-68 DOTATATE (brand name NETSPOT) radiopharmaceutical injection kits. The $56,000 IDC contract, awarded on April 10, 2020, has a period of performance through December 31, 2020. This IDC facilitates the procurement of NETSPOT radiopharmaceuticals through delivery orders for MEDCOM's nuclear medicine diagnostic imaging programs.

Under this IDC, MEDCOM has issued several firm-fixed price delivery orders to Advanced Accelerator Applications USA Inc. for the supply of NETSPOT injection kits, valued at $10,500, $14,000, and $21,000. These delivery orders, which do not have set-aside designations, support MEDCOM's requirement for the radiopharmaceutical products at its medical facility in Millburn, New Jersey. Advanced Accelerator Applications USA Inc. has received numerous federal contracts from agencies such as the VA, DHA, and NIH to provide specialized nuclear medicine products, including radiopharmaceuticals for diagnostic imaging and cancer treatment.

Generated 6/27/24, 9:33 AM